UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934

 

For the Month of November 2018

 

333-206723
(Commission File Number)

 

P.V. Nano Cell Ltd.

(Exact name of Registrant as specified in its charter)

 

8 Hamasger Street
Migdal Ha’Emek, Israel 2310102

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____

 

 

 

 

 

On November 8th, 2018, P.V. Nano Cell Ltd. (the “Issuer”) announced it has issued a press release with a letter to its shareholders. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

1

 

 

Exhibit Index

 

Exhibit No.   Description
     
99.1   Shareholder Update Letter 110718.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  P.V. Nano Cell Ltd.
     
Date November 8th, 2018 By: /s/ Dr. Fernando de la Vega
    Name: Dr. Fernando de la Vega
    Title: Chief Executive Officer

 

3